Advanced search
Publication Cover
Drug Metabolism Reviews Volume 15, 1984 - Issue 1-2
Submit an article Journal homepage
110
Views
60
CrossRef citations to date
0
Altmetric
Research Article

1. Population Pharmacokinetic Data and Parameter Estimation Based on Their First Two Statistical Moments

Stuart L. Beal Department of Laboratory Medicine, and Division of Clinical Pharmacology Departments of Medicine and Pharmacy, University of California San Francisco, California, 94143
Pages 173-193 | Published online: 22 Sep 2008

Citations (60)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (5)

David Abrial, Alain Blanc, Mohamed Réhailia, Patrick Mismetti, Colette Bouchut, Silvy Laporte-Simitsidis, Hervé Decousus & Bernard Buisson. (2000) ESTABLISHING THE DOSE-DEPENDENT DAILY VARIATIONS OF A LOW MOLECULAR WEIGHT HEPARIN (FRAXIPARINE®) THROUGH A POPULATION APPROACH ANALYSIS IN THE RAT. Chronobiology International 17:2, pages 173-185.
Read now
Xinwei Jia & Jerry R. Neldelman. (1996) Errors in time in pharmacokinetic studies. Journal of Biopharmaceutical Statistics 6:3, pages 303-318.
Read now
Alison A. Carter, Sara E. Rosenbaum & Michael N. Dudley. (1995) Review of Methods in Population Pharmacokinetics. Clinical Research and Regulatory Affairs 12:1, pages 1-21.
Read now
Sara E. Rosenbaum, Alison A. Carter & Michael N. Dudley. (1995) Population Pharmacokinetics: Fundamentals, Methods and Applications. Drug Development and Industrial Pharmacy 21:9, pages 1115-1141.
Read now
Kathryn Hirst, Gary O. Zerbe, David W. Boyle & Randall B. Wilkening. (1991) On nonlinear random effects models for repeated measurements. Communications in Statistics - Simulation and Computation 20:2-3, pages 463-478.
Read now

Articles from other publishers (55)

Kévin Koloskoff, Sylvain Benito, Lucie Chambon, Frédéric Dayan, Pierre Marquet, Evelyne Jacqz-Aigrain & Jean-Baptiste Woillard. (2023) Limited sampling strategy and population pharmacokinetic model of mycophenolic acid in pediatric patients with systemic lupus erythematosus: application of a double gamma absorption model with SAEM algorithm. European Journal of Clinical Pharmacology.
Crossref
Sameer Doshi, Hui Wang & Vincent Chow. (2022) Establishing PK Equivalence Between Adalimumab and ABP 501 in the Presence of Antidrug Antibodies Using Population PK Modeling. Clinical Therapeutics 44:1, pages 111-122.
Crossref
John David Clements, Min Zhu, Mita Kuchimanchi, Bianca Terminello & Sameer Doshi. (2019) Population Pharmacokinetics of Blinatumomab in Pediatric and Adult Patients with Hematological Malignancies. Clinical Pharmacokinetics 59:4, pages 463-474.
Crossref
Yilong Zhang, Mita Kuchimanchi, Min Zhu, Sameer Doshi, Tien Hoang & Sreeneeranj Kasichayanula. (2016) Assessment of pharmacokinetic interaction between rilotumumab and epirubicin, cisplatin and capecitabine (ECX) in a Phase 3 study in gastric cancer. British Journal of Clinical Pharmacology 83:5, pages 1048-1055.
Crossref
R. Jelliffe. 2017. Individualized Drug Therapy for Patients. Individualized Drug Therapy for Patients 19 25 .
Elske Sitsen, Erik Olofsen, Agnes Lesman, Albert Dahan & Jaap Vuyk. (2016) Epidural Blockade Affects the Pharmacokinetics of Propofol in Surgical Patients. Anesthesia & Analgesia 122:5, pages 1341-1349.
Crossref
Tarjinder Sahota, Meindert Danhof & Oscar Della Pasqua. (2016) Pharmacology-based toxicity assessment: towards quantitative risk prediction in humans. Mutagenesis 31:3, pages 359-374.
Crossref
Min-Sun Kwak, Su Jong Yu, Jung-Hwan Yoon, Sung-Hee Lee, Soo-Mi Lee, Jeong-Hoon Lee, Yoon Jun Kim, Hyo-Suk Lee & Chung Yong Kim. (2015) Synergistic anti-tumor efficacy of doxorubicin and flavopiridol in an in vivo hepatocellular carcinoma model. Journal of Cancer Research and Clinical Oncology 141:11, pages 2037-2045.
Crossref
Mehdi Boroujerdi. 2015. Pharmacokinetics and Toxicokinetics. Pharmacokinetics and Toxicokinetics 479 488 .
Soham Chakraborty & Pathik Kumar Mandal. (2015) SPC based on growth models for monitoring the process of hydrogenation of edible oil. Journal of Food Engineering 146, pages 192-203.
Crossref
Andr? Schaeftlein, Iris K. Minichmayr & Charlotte Kloft. (2014) Population pharmacokinetics meets microdialysis: Benefits, pitfalls and necessities of new analysis approaches for human microdialysis data. European Journal of Pharmaceutical Sciences 57, pages 68-73.
Crossref
Alexandre Sostelly, Léa Payen, Jérôme Guitton, Attilio Di Pietro, Pierre Falson, Mylène Honorat, Glaucio Valdameri, Annabelle Geze, Ahcène Boumendjel, Gilles Freyer & Michel Tod. (2013) A template model for studying anticancer drug efflux transporter inhibitors in vitro . Fundamental & Clinical Pharmacology 27:5, pages 544-556.
Crossref
Su Jong Yu, Jung-Hwan Yoon, Jong-In Yang, Eun Ju Cho, Min Sun Kwak, Eun Sun Jang, Jeong-Hoon Lee, Yoon Jun Kim, Hyo-Suk Lee & Chung Yong Kim. (2012) Enhancement of hexokinase II inhibitor-induced apoptosis in hepatocellular carcinoma cells via augmenting ER stress and anti-angiogenesis by protein disulfide isomerase inhibition. Journal of Bioenergetics and Biomembranes 44:1, pages 101-115.
Crossref
Matthew M. Hutmacher, Jonathan L. French, Sriram Krishnaswami & Sujatha Menon. (2011) Estimating transformations for repeated measures modeling of continuous bounded outcome data. Statistics in Medicine 30:9, pages 935-949.
Crossref
Jim E. RiviereJason Chittenden. 2011. Comparative Pharmacokinetics. Comparative Pharmacokinetics 347 378 .
Robert S. Parker & Gilles Clermont. (2010) Systems engineering medicine: engineering the inflammation response to infectious and traumatic challenges. Journal of The Royal Society Interface 7:48, pages 989-1013.
Crossref
Won Kim, Jung-Hwan Yoon, Jung-Ryul Kim, In-Jin Jang, Yung-Jue Bang, Yoon-Jun Kim & Hyo-Suk Lee. (2008) Synergistic anti-tumor efficacy of lovastatin and protein kinase C-beta inhibitor in hepatocellular carcinoma. Cancer Chemotherapy and Pharmacology 64:3, pages 497-507.
Crossref
Gabriele Fliss, Alexander Staab, Christiane Tillmann, Dirk Trommeshauser, Hans G. Schaefer & Charlotte Kloft. (2007) Population Pharmacokinetic Data Analysis of Cilobradine, an If Channel Blocker. Pharmaceutical Research 25:2, pages 359-368.
Crossref
Thorsten Lehr, Alexander Staab & Hans Günter Schäfer. 2007. Biosimulation in Drug Development. Biosimulation in Drug Development 447 483 .
Douglas J. Eleveld, Johannes H. Proost & J. Mark K. H. Wierda. (2006) Twitch Potentiation Influences the Time Course of Twitch Depression in Muscle Relaxant Studies: A Pharmacokinetic-Pharmacodynamic Explanation. Journal of Pharmacokinetics and Pharmacodynamics 33:6, pages 795-806.
Crossref
Aida Bustad, Dimiter Terziivanov, Robert Leary, Ruediger Port, Alan Schumitzky & Roger Jelliffe. (2006) Parametric and Nonparametric Population Methods. Clinical Pharmacokinetics 45:4, pages 365-383.
Crossref
Ene I Ette & Paul J Williams. (2004) Population Pharmacokinetics II: Estimation Methods. Annals of Pharmacotherapy 38:11, pages 1907-1915.
Crossref
K.K. Barakat .. (2004) Effect of Some Water Pollutants on the Biology of the Nile Bolti, Oreochromis niloticus. Pakistan Journal of Biological Sciences 7:3, pages 305-308.
Crossref
Verena N'Gankam, Dominik Uehlinger, Bernhard Dick, Brigitte M. Frey & Felix J. Frey. (2002) Increased cortisol metabolites and reduced activity of 11β-hydroxysteroid dehydrogenase in patients on hemodialysis. Kidney International 61:5, pages 1859-1866.
Crossref
Jeffrey Barrett. 2002. Pharmacokinetics in Drug Discovery and Development. Pharmacokinetics in Drug Discovery and Development.
Guenther Hochhaus, Jeffrey S. Barrett & Hartmut Derendorf. (2013) Evolution of Pharmacokinetics and Pharmacokinetic/Dynamic Correlations during the 20th Century. The Journal of Clinical Pharmacology 40:9, pages 908-917.
Crossref
Roger Jelliffe, Alan Schumitzky & Michael Van Guilder. (2000) Population Pharmacokinetics/Pharmacodynamics Modeling: Parametric and Nonparametric Methods. Therapeutic Drug Monitoring 22:3, pages 354-365.
Crossref
Marc Pfister, Franziska Schaedeli, Felix J. Frey & Dominik E. Uehlinger. (2001) Pharmacokinetics and haemodynamics of candesartan cilexetil in hypertensive patients on regular haemodialysis. British Journal of Clinical Pharmacology 47:6, pages 645-651.
Crossref
Silvy Laporte, Patrick Mismetti, Pascal Piquet, Sylvie Doubine, Anita Touchot & Herv? Decousus. (1999) Population pharmacokinetic of nadroparin calcium (Fraxiparine?) in children hospitalised for open heart surgery. European Journal of Pharmaceutical Sciences 8:2, pages 119-125.
Crossref
T. MARTÍN‐JIMÉNEZ & J.E. RIVIERE. (2002) Population pharmacokinetics in veterinary medicine: Potential use for therapeutic drug monitoring and prediction of tissue residues. Journal of Veterinary Pharmacology and Therapeutics 21:3, pages 167-189.
Crossref
Roger W. Jelliffe, Pilar Gomis, Babak Tahani, Joel Ruskin & Fred R. Sattler. (1997) A Population Pharmacokinetic Model of Trimethoprim in Patients With Pneumocystis Pneumonia, Made With Parametric and Nonparametric Methods. Therapeutic Drug Monitoring 19:4, pages 450-459.
Crossref
Sian Bigora, Deborah Piscitelli, James Dowell, Jackie Butler, Colm Farrell, John Devane & David Young. 1997. In Vitro-in Vivo Correlations. In Vitro-in Vivo Correlations 207 215 .
O. Richter, B. Diekkrüger & P. Nörtersheuser. 1996. Environmental Fate Modelling of Pesticides. Environmental Fate Modelling of Pesticides 267 275 .
D E Uehlinger, F Schaedeli, M Kinzig, F Sörgel & F J Frey. (1996) Pharmacokinetics of fleroxacin after multiple oral dosing in patients receiving regular hemodialysis. Antimicrobial Agents and Chemotherapy 40:8, pages 1903-1909.
Crossref
Karin E. Fattinger & Davide Verotta. (1995) A nonparametric subject-specific population method for deconvolution: II. External validation. Journal of Pharmacokinetics and Biopharmaceutics 23:6, pages 611-634.
Crossref
Karin E. Fattinger & Davide Verotta. (1995) A nonparametric subject-specific population method for deconvolution: I. Description, internal validation, and real data examples. Journal of Pharmacokinetics and Biopharmaceutics 23:6, pages 581-610.
Crossref
Pascal Girard, Silvy Laporte‐Simitsidis, Patrick Mismetti, Hervé Decousus & Jean‐Pierre Boissel. (2007) INFLUENCE OF CONFOUNDING FACTORS ON DESIGNS FOR DOSE–EFFECT RELATIONSHIP ESTIMATES. Statistics in Medicine 14:9, pages 987-1005.
Crossref
Roger W. Jelliffe, Pascal Maire, Fred Sattler, Pilar Gomis & Babak Tahani. (1994) Adaptive control of drug dosage regimens: Basic foundations, relevant issues, and clinical examples. International Journal of Bio-Medical Computing 36:1-2, pages 1-23.
Crossref
J.-L. Steimer, S. Vozeh, A. Racine-Poon, N. Holford & R. O’Neill. 1994. Pharmacokinetics of Drugs. Pharmacokinetics of Drugs 405 451 .
A. Lindberg‐Freijs & M. O. Karlsson. (2006) Dose dependent absorption and linear disposition of cyclosporin A in rat. Biopharmaceutics & Drug Disposition 15:1, pages 75-86.
Crossref
W. R. Gilks, D. G. Clayton, D. J. Spiegelhalter, N. G. Best, A. J. McNeil, L. D. Sharples & A. J. Kirby. (2018) Modelling Complexity: Applications of Gibbs Sampling in Medicine. Journal of the Royal Statistical Society: Series B (Methodological) 55:1, pages 39-52.
Crossref
Jonathan P. Vielhaber, Jeanne V. Kuhlman & Jeffrey S. Barrett. (1993) NONMEM version III implementation on a VAX 9000: a DCL procedure for single-step execution and the unrealized advantage of a vectorizing FORTRAN compiler. Computer Methods and Programs in Biomedicine 40:2, pages 103-115.
Crossref
J. H. Botha, I. Tyrannes, R. Miller & A. Wesley. (1993) Determination of theophylline clearance in South African children. European Journal of Clinical Pharmacology 44:4, pages 369-375.
Crossref
Warren F. Dodge, Roger W. Jelliffe, C. Joan Richardson, Renee A. Bellanger, James A. Hokanson & Wayne R. Snodgrass. (2012) Population Pharmacokinetic Models. Drug Investigation 5:4, pages 206-211.
Crossref
Marie Davidian & A. Ronald Gallant. (1992) Smooth nonparametric maximum likelihood estimation for population pharmacokinetics, with application to quinidine. Journal of Pharmacokinetics and Biopharmaceutics 20:5, pages 529-556.
Crossref
Kem F. Phillips. (1992) Response to “An evaluation of point and interval estimates in population pharmacokinetics using NONMEM analysis” by Whiteet al.. Journal of Pharmacokinetics and Biopharmaceutics 20:4, pages 389-395.
Crossref
Merrill J. Egorin. 1992. New Approaches in Cancer Pharmacology: Drug Design and Development. New Approaches in Cancer Pharmacology: Drug Design and Development 75 91 .
Yukiya Hashimoto & Lewis B. Sheiner. (1991) Designs for population pharmacodynamics: Value of pharmacokinetic data and population analysis. Journal of Pharmacokinetics and Biopharmaceutics 19:3, pages 333-353.
Crossref
Lewis B. Sheiner, Yukiya Hashimoto & Stuart L. Beal. (1991) A simulation study comparing designs for dose ranging. Statistics in Medicine 10:3, pages 303-321.
Crossref
R.W. Jelliffe. (1991) Optimal Design Of Drug Dosage Regimens. Optimal Design Of Drug Dosage Regimens.
John H. Rodman & William E. Evans. 1991. Advanced Methods of Pharmacokinetic and Pharmacodynamic Systems Analysis. Advanced Methods of Pharmacokinetic and Pharmacodynamic Systems Analysis 177 183 .
Samuel Vozeh, Pierre O. Maitre & Donald R. Stanski. (1990) Evaluation of population (NONMEM) pharmacokinetic parameter estimates. Journal of Pharmacokinetics and Biopharmaceutics 18:2, pages 161-173.
Crossref
L. D. B. Kinabo & Q. A. McKellar. (1989) Current models in pharmacokinetics: Applications in veterinary pharmacology. Veterinary Research Communications 13:2, pages 141-157.
Crossref
Alain Mallet, France Mentr?Jean -Louis Steimer & Fran?ois Lokiec. (1988) Nonparametric maximum likelihood estimation for population pharmacokinetics, with application to cyclosporine. Journal of Pharmacokinetics and Biopharmaceutics 16:3, pages 311-327.
Crossref
D. R. Mungall, T. M. Ludden, J. Marshall, D. W. Hawkins, R. L. Talbert & M. H. Crawford. (1985) Population pharmacokinetics of racemic warfarin in adult patients. Journal of Pharmacokinetics and Biopharmaceutics 13:3, pages 213-227.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.